MannKind Corp (MNKD)
6.90
+0.02
(+0.29%)
USD |
NASDAQ |
Nov 21, 16:00
6.95
+0.05
(+0.72%)
After-Hours: 20:00
MannKind Profit Margin (Quarterly): 16.48% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 16.48% |
| June 30, 2024 | -2.78% |
| March 31, 2024 | 16.04% |
| December 31, 2023 | 2.40% |
| September 30, 2023 | 3.36% |
| June 30, 2023 | -10.83% |
| March 31, 2023 | -24.11% |
| December 31, 2022 | -49.77% |
| September 30, 2022 | -43.97% |
| June 30, 2022 | -153.6% |
| March 31, 2022 | -216.8% |
| December 31, 2021 | -224.2% |
| September 30, 2021 | -19.93% |
| June 30, 2021 | -152.6% |
| March 31, 2021 | -74.08% |
| December 31, 2020 | -143.2% |
| September 30, 2020 | -73.31% |
| June 30, 2020 | -67.83% |
| March 31, 2020 | -57.42% |
| December 31, 2019 | -89.18% |
| September 30, 2019 | -71.05% |
| June 30, 2019 | -82.57% |
| March 31, 2019 | -85.30% |
| December 31, 2018 | -60.82% |
| September 30, 2018 | -540.8% |
| Date | Value |
|---|---|
| June 30, 2018 | -582.5% |
| March 31, 2018 | -876.9% |
| December 31, 2017 | -723.7% |
| September 30, 2017 | -1.61K% |
| June 30, 2017 | -1.63K% |
| March 31, 2017 | -542.5% |
| December 31, 2016 | |
| September 30, 2016 | 77.93% |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | -122.4K% |
| June 30, 2012 |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-224.2%
Minimum
Dec 2021
16.48%
Maximum
Sep 2024
-68.27%
Average
-53.60%
Median
Profit Margin (Quarterly) Benchmarks
| Mirum Pharmaceuticals Inc | -15.75% |
| NovaBay Pharmaceuticals Inc | -49.65% |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | 4.94% |
| Return on Invested Capital | 110.1% |
| Gross Profit Margin (Quarterly) | 74.28% |
| Operating Margin (Quarterly) | 21.71% |
| Return on Net Operating Assets | 16.10% |